Insulin lispro therapy in pregnancies complicated by type 1 diabetes: Glycemic control and maternal and fetal outcomes

Endocrine Practice

Volumn 9, Issue 3, 2003, Pages 187-193

  Garg, Satish K ^a   Frias, Juan P ^a   Anil, Sunitha ^a   Gottlieb, Peter A ^a   MacKenzie, Todd ^a   Jackson, William E ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN LISPRO;

ADULT; ALBUMINURIA; ARTICLE; BIRTH WEIGHT; CONGENITAL MALFORMATION; DIABETIC RETINOPATHY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MACROSOMIA; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; RETROSPECTIVE STUDY;

ABNORMALITIES; ADULT; ALBUMINURIA; BIRTH WEIGHT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; FETAL MACROSOMIA; GESTATIONAL AGE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 2342648230     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.9.3.187     Document Type: Article

References (53)

1. Buchanan TA. Pregnancy in preexisting diabetes. In: National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995: 719-733. NIH Publication No. 95-1468.
2. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304:1331-1334.
3. Simpson JL, Elias S, Martin AO, Palmer MS, Ogata ES, Radvany RA. Diabetes in pregnancy, Northwestern University series (1977-1981). I. Prospective study of anomalies in offspring of mothers with diabetes mellitus. Am J Obstet Gynecol. 1983;146:263-270.
4. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology. 1989;39:225-231.
5. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA. 1991;265:731-736.
6. Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia. 2000;43:79-82.
7. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development - Diabetes in Early Pregnancy Study. Am J Obstet Gynecol. 1991;164(1 Pt 1):103-111.
8. Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care. 1992;15:1251-1257.
9. Hunter DJ, Burrows RF, Mohide PT, Whyte RK. Influence of maternal insulin-dependent diabetes mellitus on neonatal morbidity. CMAJ. 1993;149:47-52.
10. Rey E, Attie C, Bonin A. The effects of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol. 1999;181:202-206.
11. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333:1237-1241.
12. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
13. Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol. 1995;85:417-422.
14. Rosenn GM, Miodovnik M. Glycemic control in the diabetic pregnancy: is tighter always better? J Matern-Fetal Med. 2000;9:29-34.
15. Garg SK, Carmain JA, Braddy KC, et al. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. Diabet Med. 1996;13:47-52.
16. Rutledge KS, Chase HP, Klingensmith GJ, Walravens PA, Slover RH, Garg SK. Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics. 1997;100: 968-972.
17. Garg SK, Anderson JH, Perry SV, et al. Long-term efficacy of Humalog in subjects with type 1 diabetes mellitus. Diabet Med. 1999;16:384-387.
18. Anderson JH Jr, Brunelle RL, Koivisto VA, et al (Multicenter Insulin Lispro Study Group). Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes. 1997;46:265-270.
19. Davey P, Grainger D, MacMillan J, Rajan N, Aristides M, Gliksman M. Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis. Clin Ther. 1997;19:656-674.
20. Heller SR, Amiel SA, Mansell P (U.K. Lispro Study Group). Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. Diabetes Care. 1999;22:1607-1611.
21. Diamond T, Kormas N. Possible adverse fetal effect of insulin lispro [letter] [with discussion]. N Engl J Med. 1997;337:1009-1010.
22. Kitzmiller JL, Main E, Ward B, Theiss T, Peterson DL. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy [letter]. Diabetes Care. 1999;22:874-876.
23. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care. 1999;22:1422-1427.
24. Bhattacharyya A, Vice PA. Insulin lispro, pregnancy, and retinopathy [letter]. Diabetes Care. 1999;22:2101-2104.
25. Bhattacharyya A, Brown S, Hughes S, Vice PA. Insulin lispro and regular insulin in pregnancy. QJM. 2001;94: 255-260.
26. Buchbinder A, Miodovnik M, McElvy S, et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol. 2000;183:1162-1165.
27. Garg SK, Chase HP, Marshall G, Hoops SL, Holmes DL, Jackson WE. Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. JAMA. 1994;271:1099-1102.
28. Diabetic Retinopathy Study Research Group. Diabetic retinopathy study. Report number 6: Design, methods, and baseline results. Report number 7: A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci. 1981;21(1 Pt 2):210-226.
29. Carter JS, Houston CA, Gilliland SS, et al. Rapid HbA1c testing in a community setting. Diabetes Care. 1996;19:764-767.
30. Chase HP, Garg SK, Harris S, Marshall G, Hoops S. Elevation of resting and exercise blood pressures in subjects with type I diabetes and relation to albuminuria. J Diabetes Complications. 1992;6:138-142.
31. Osberg I, Chase HP, Garg SK, et al. Effects of storage time and temperature on measurement of small concentrations of albumin in urine. Clin Chem. 1990;36(8 Pt 1):1428-1430.
32. American Diabetes Association. Preconception care of women with diabetes. Diabetes Care. 2000;23(Suppl 1):S65-S68.
33. McElvy SS, Miodovnik M, Rosenn B, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern-Fetal Med. 2000;9:14-20.
34. Kotsanos JG, Vignati L, Huster W, et al. Health-related quality-of-life results from multinational clinical trials of insulin lispro: assessing the benefits of a new diabetes therapy. Diabetes Care. 1997;20:948-958.
35. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T. Insulin lispro in CSII: results of a double-blind crossover study [erratum in Diabetes. 1997;46:1239]. Diabetes. 1997;46:440-443.
36. Melki V, Renard E, Lassmann-Vague V, et al. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care. 1998;21:977-982.
37. Renner R, Pfujtzner A, Trautmann M, Harzer O, Sauter K, Landgraf R (German Humalog-CSII Study Group). Use of insulin lispro in continuous subcutaneous insulin infusion treatment: results of a multicenter trial. Diabetes Care. 1999;22:784-788.
38. Johansson UB, Adamson UC, Lins PE, Wredling RA. Improved blood glucose variability, HbA1c Insuman infusate and less insulin requirement in IDDM patients using insulin lispro in CSII: the Swedish Multicenter Lispro Insulin Study. Diabetes Metab. 2000;26:192-196.
39. Lalli C, Ciofetta M, Del Sindaco P, et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care. 1999;22:468-477.
40. Ebeling P, Jansson PA, Smith U, Lalli C, Bolli GB, Koivisto VA. Strategies toward improved control during insulin lispro therapy in IDDM: importance of basal insulin. Diabetes Care. 1997;20:1287-1289.
41. Jansson PA, Ebeling P, Smith U, et al. Improved glycemic control can be better maintained with insulin lispro than with human regular insulin. Diabetes Nutr Metab. 1998;11:194-199.
42. Jovanovic L. Retinopathy risk: what is responsible? Hormones, hyperglycemia, or Humalog? Response to Kitzmiller et al [erratum in Diabetes Care. 1999;22:1229]. Diabetes Care. 1999;22:846-848.
43. Chase HP, Lockspeiser T, Peery B, et al. The impact of the Diabetes Control and Complications Trial and Humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care. 2001;24:430-434.
44. Brunelle BL, Llewelyn J, Anderson JH Jr, Gale EA, Koivisto VA. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care. 1998;21:1726-1731.
45. Reece EA, Homko CJ, Hagay Z. Diabetic retinopathy in pregnancy. Obstet Gynecol Clin North Am. 1996;23:161-171.
46. Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13:34-40.
47. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care. 1995;18:631-637.
48. Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial. Diabetes Care. 2000;23:1084-1091.
49. Healy K, Jovanovic-Peterson L, Peterson CM. Pancreatic disorders of pregnancy: pregestational diabetes. Endocrinol Metab Clin North Am. 1995;24:73-101.
50. Jensen GM, Moore LG. The effect of high altitude and other risk factors on birthweight: independent or interactive effects? Am J Public Health. 1997;87:1003-1007.
51. Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care. 1996;19:514-541.
52. Rassmusen SA, Moore CA, Paulozzi LJ, Rhodenhiser EP. Risk for birth defects among premature infants: a population-based study. J Pediatr. 2001;138:668-673.
53. Montgomery A, Miller L. Using the Colorado birth defects monitoring program to connect families with services for children with special needs. Teratology. 2001;64(Suppl 1):S42-S46.